These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1447213)

  • 1. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
    J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
    Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
    J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.
    Krych M; Clemenza L; Howdeshell D; Hauhart R; Hourcade D; Atkinson JP
    J Biol Chem; 1994 May; 269(18):13273-8. PubMed ID: 8175757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
    Krych M; Hourcade D; Atkinson JP
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4353-7. PubMed ID: 1827918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
    Mossakowska D; Dodd I; Pindar W; Smith RA
    Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
    J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR; Fearon DT
    J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
    Furtado PB; Huang CY; Ihyembe D; Hammond RA; Marsh HC; Perkins SJ
    J Mol Biol; 2008 Jan; 375(1):102-18. PubMed ID: 18028942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
    Klickstein LB; Barbashov SF; Liu T; Jack RM; Nicholson-Weller A
    Immunity; 1997 Sep; 7(3):345-55. PubMed ID: 9324355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
    J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
    Birmingham DJ; Irshaid F; Gavit KF; Nagaraja HN; Yu CY; Rovin BH; Hebert LA
    Mol Immunol; 2007 Jul; 44(14):3510-6. PubMed ID: 17467802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
    Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
    J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
    J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.